EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Mutation to Manifestation: Penetrance in Amyotrophic Lateral Sclerosis

Elodie Richard, Sally Al-Hajj Vourc'h, Sylviane Marouillat iD, Stéphane Beltran iD, Hélène Blasco, Philippe Corcia iD, Patrick Vourc'h

Genes · 2026

DOI: 10.3390/genes17050576 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2026. Verfasst von Elodie Richard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Biochimie et Biologie Moléculaire, CHRU de Tours, 37044 Tours, France. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Penetrance, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by progressive loss of motor neurons in the brain and spinal cord. While most cases are sporadic, around 10% are familial. Recent genetic studies show that many apparently isolated cases carry pathogenic mutations, highlighting the importance of penetrance, the probability that a causal mutation manifests clinically. This review focuses on mutation penetrance in ALS (C9orf72, SOD1, TARDBP, FUS genes), its variability across genes, age, and environmental or genetic modifiers, and its implications for genetic counseling. Identification of pathogenic mutations informs the monitoring of relatives and, in some cases, gives access to targeted therapies or clinical trials. Counseling of asymptomatic relatives must consider incomplete penetrance, which can lead to delayed or absent disease manifestation. ALS exists on a clinical and genetic continuum including related disorders, such as frontotemporal dementia, further influencing risk interpretation. Advances in panel, whole-exome and whole-genome sequencing refine our understanding of penetrance and enable precise diagnostics, and potential tailored therapies. Understanding penetrance is therefore essential to translate mutation discovery into informed clinical decisions and genetic counseling in ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisPenetranceMutationHumansSuperoxide Dismutase-1RNA-Binding Protein FUSC9orf72 ProteinGenetic CounselingDNA-Binding ProteinsGenetic Predisposition to Disease

Stichwörter der Autor:innen

ALSgenetic counselinggeneticsvariable expressivity

Substanzen

Superoxide Dismutase-1RNA-Binding Protein FUSSOD1 protein, humanC9orf72 ProteinDNA-Binding ProteinsFUS protein, humanC9orf72 protein, humanTARDBP protein, human

Autor:innen und Institutionen

  • Service de Biochimie et Biologie Moléculaire, CHRU de Tours, 37044 Tours, France.
  • Centre de Référence SLA et Autres Maladies du Neurone Moteur, CHRU de Tours, 37044 Tours, France.
  • Imaging Brain & Neuropsychiatry IBraiN U1253, INSERM, Université de Tours, 37020 Tours, France.

ORCID-Profile: Sylviane Marouillat, Stéphane Beltran, Philippe Corcia

Zitieren

APA

Richard, E., Al-Hajj Vourc'h, S., Marouillat, S., Beltran, S., Blasco, H., Corcia, P., & Vourc'h, P. (2026). From Mutation to Manifestation: Penetrance in Amyotrophic Lateral Sclerosis. Genes. https://doi.org/10.3390/genes17050576

Vancouver

Richard E, Al-Hajj Vourc'h S, Marouillat S, Beltran S, Blasco H, Corcia P, et al. From Mutation to Manifestation: Penetrance in Amyotrophic Lateral Sclerosis. Genes. 2026. doi:10.3390/genes17050576

BibTeX
@article{Richard2026,
  author = {Richard, Elodie and Al-Hajj Vourc'h, Sally and Marouillat, Sylviane and Beltran, Stéphane and Blasco, Hélène and Corcia, Philippe and Vourc'h, Patrick},
  title = {From Mutation to Manifestation: Penetrance in Amyotrophic Lateral Sclerosis},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17050576}
}
Kostenlos starten →